Brief: Eubiologics Gets An IND Approval For Phase I/II Clinical Trial Of 'EuCorVac-19' In Korea

EuBiologics

21/01/2021 13:57

Jan 21 (Reuters) - EuBiologics Co Ltd  206650.KQ :
    * EUBIOLOGICS GETS AN IND APPROVAL FOR PHASE I/II CLINICAL
TRIAL
OF 'EUCORVAC-19' IN KOREA
    * EU BIOLOGICS CO LTD -  STARTING PHASE I/II TRIAL IN
EUNPYEONG
ST. MARY'S HOSPITAL OF 'EUCORVAC-19' IN KOREA

Source text for Eikon:  ID:nBw6fHxnHa 
Further company coverage:  206650.KQ 

 ((Reuters.Briefs@thomsonreuters.com;))